Renal function was analyzed according to the presence or absence of CKD at the time of mTOR inhibitor initiation, and a significant improvement in renal function was noted in the CKD group after 12 months of mTOR inhibitor use. This evidence concerns the gene MTOR and chronic kidney disease.